BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29183775)

  • 1. Novel effects of phytoestrogenic soy isoflavones on serum calcium and chloride in premenopausal women: A 2-year double-blind, randomized, placebo-controlled study.
    Lu LW; Chen NW; Nayeem F; Ramanujam VS; Kuo YF; Brunder DG; Nagamani M; Anderson KE
    Clin Nutr; 2018 Dec; 37(6 Pt A):1862-1870. PubMed ID: 29183775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daidzein and genistein have differential effects in decreasing whole body bone mineral density but had no effect on hip and spine density in premenopausal women: A 2-year randomized, double-blind, placebo-controlled study.
    Nayeem F; Chen NW; Nagamani M; Anderson KE; Lu LW
    Nutr Res; 2019 Aug; 68():70-81. PubMed ID: 31421395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soy isoflavones interact with calcium and contribute to blood pressure homeostasis in women: a randomized, double-blind, placebo controlled trial.
    Lu LW; Chen NW; Nayeem F; Nagamani M; Anderson KE
    Eur J Nutr; 2020 Sep; 59(6):2369-2381. PubMed ID: 31535213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
    Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
    Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of soy isoflavones in normal human breast tissue.
    Bolca S; Urpi-Sarda M; Blondeel P; Roche N; Vanhaecke L; Possemiers S; Al-Maharik N; Botting N; De Keukeleire D; Bracke M; Heyerick A; Manach C; Depypere H
    Am J Clin Nutr; 2010 Apr; 91(4):976-84. PubMed ID: 20164315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study.
    Tai TY; Tsai KS; Tu ST; Wu JS; Chang CI; Chen CL; Shaw NS; Peng HY; Wang SY; Wu CH
    Osteoporos Int; 2012 May; 23(5):1571-80. PubMed ID: 21901480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy isoflavones decrease fibroglandular breast tissue measured by magnetic resonance imaging in premenopausal women: A 2-year randomized double-blind placebo controlled clinical trial.
    Lu LW; Chen NW; Brunder DG; Nayeem F; Nagamani M; Nishino TK; Anderson KE; Khamapirad T
    Clin Nutr ESPEN; 2022 Dec; 52():158-168. PubMed ID: 36513449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women.
    Kotsopoulos D; Dalais FS; Liang YL; McGrath BP; Teede HJ
    Climacteric; 2000 Sep; 3(3):161-7. PubMed ID: 11910617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of consumption of soy isoflavones on behavioural, somatic and affective symptoms in women with premenstrual syndrome.
    Bryant M; Cassidy A; Hill C; Powell J; Talbot D; Dye L
    Br J Nutr; 2005 May; 93(5):731-9. PubMed ID: 15975174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity.
    Zhang Y; Wang GJ; Song TT; Murphy PA; Hendrich S
    J Nutr; 1999 May; 129(5):957-62. PubMed ID: 10222386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function--a 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension.
    Liu ZM; Ho SC; Chen YM; Tomlinson B; Ho S; To K; Woo J
    Eur J Clin Nutr; 2015 Oct; 69(10):1161-8. PubMed ID: 25782428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton.
    Heinonen SM; Hoikkala A; Wähälä K; Adlercreutz H
    J Steroid Biochem Mol Biol; 2003 Dec; 87(4-5):285-99. PubMed ID: 14698210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women.
    Setchell KD; Faughnan MS; Avades T; Zimmer-Nechemias L; Brown NM; Wolfe BE; Brashear WT; Desai P; Oldfield MF; Botting NP; Cassidy A
    Am J Clin Nutr; 2003 Feb; 77(2):411-9. PubMed ID: 12540402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore.
    Seow A; Shi CY; Franke AA; Hankin JH; Lee HP; Yu MC
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):135-40. PubMed ID: 9488588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women.
    Bloedon LT; Jeffcoat AR; Lopaczynski W; Schell MJ; Black TM; Dix KJ; Thomas BF; Albright C; Busby MG; Crowell JA; Zeisel SH
    Am J Clin Nutr; 2002 Nov; 76(5):1126-37. PubMed ID: 12399289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention.
    Lu LJ; Anderson KE; Grady JJ; Kohen F; Nagamani M
    Cancer Res; 2000 Aug; 60(15):4112-21. PubMed ID: 10945618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women.
    Teede HJ; Dalais FS; McGrath BP
    Am J Clin Nutr; 2004 Mar; 79(3):396-401. PubMed ID: 14985213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phytoestrogens on bone mineral density during the menopause transition: a systematic review of randomized, controlled trials.
    Abdi F; Alimoradi Z; Haqi P; Mahdizad F
    Climacteric; 2016 Dec; 19(6):535-545. PubMed ID: 27710141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a soymilk supplement containing isoflavones on urinary F2 isoprostane levels in premenopausal women.
    Nhan S; Anderson KE; Nagamani M; Grady JJ; Lu LJ
    Nutr Cancer; 2005; 53(1):73-81. PubMed ID: 16351509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily intake and urinary excretion of genistein and daidzein by infants fed soy- or dairy-based infant formulas.
    Irvine CH; Shand N; Fitzpatrick MG; Alexander SL
    Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1462S-1465S. PubMed ID: 9848517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.